Screening of Obstructive Sleep Apnea Syndrome in Residents of a Unit of Long-term Care Under Mixed Food

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02839499

Enrollment

Registered

2016-07-21

Start date

2016-11-15

Completion date

2017-03-01

Last updated

2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Syndrome

Keywords

seniors, mixed food, normal texture food

Brief summary

Obstructive sleep apnea is a condition that affects 40% to 62% of the population aged over 60 years with major consequences especially on the cardiovascular system. This syndrome consists of a staff of the pharyngeal muscles. These muscles are also involved in swallowing phenomena and chews, or many elderly patients are subjected to a mixed diet, logically leading to atrophy of the muscles aerodigestive crossroads. Muscle wasting ENT induced a mixed food could promote collapsibility of VAS, exposing the individual to a higher risk of apnea and hypopnea during sleep. The objective of this study is to determine if there is a significant increase in the prevalence of obstructive sleep apnea syndrome in the elderly patients residing in long term care units, receiving a mixed food compared to residents in supply to normal texture.

Interventions

DEVICERU sleeping®

Each patient included in the study has a test by RU-sleeping. The diagnosis of obstructive sleep apnea syndrome will be asked for an index of respiratory events estimated as greater than or equal to 10.

OTHERautonomy scale (ADL and AGGIR)

autonomy data

OTHERvarious activity scale (IADL)

activity of life data

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

70 Years to No maximum

Healthy volunteers

Inclusion criteria

* Resident of a unit of long-term care * Recipient or affiliated with Social Security * Signature of consent by the patient, guardian or person of trust and mixed food or normal texture food

Exclusion criteria

* OSA diagnosed and treated earlier * Patients with an abnormal upper airway out edentation * Patients unable to give informed consent and having no confidence in individual capacity to do so. * Patients with a gastrostomy or jejunostomy

Design outcomes

Primary

Measure	Time frame	Description
measure of the index of respiratory events	up to 24 hours	measured with holter (RU-sleeping®)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026